HGEN News and Press, Humanigen Inc. From 09/23/20

Humanigen (HGEN) has collaborated with Thermo Fisher Scientific (TMO) to expand the manufacturing capacity for lenzilumab, for use in COVID-19, to support a potential Emergency Use Authorization ((EUA)). "Manufacturing preparation, precision and expertise are critical as we execute on an aggr...

Collaboration further strengthens manufacturing capabilities and capacity in advance of potential Emergency Use Authorization in 2020 Humanigen, Inc. , (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing an...

Management presentation Wednesday, September 23 at 10:50 a.m. EDT Humanigen, Inc. , (Nasdaq: HGEN) (“Humanigen”), announced today that management will present a company overview and business update at the Oppenheimer Fall Healthcare Life Sciences & MedT...

Humanigen, Inc. (Nasdaq: HGEN), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab™, announced today that it has completed its previously announce...

Gainers: Cubic (CUB) +30%.AcelRx Pharmaceuticals (ACRX) +23%.VerifyMe (VRME) +22%.Cardiff Oncology (CRDF) +19%.Roku (ROKU) +16%.Trinity Place (TPHS) +14%.Super League Gaming (SLGG) +12%.Humanigen (HGEN) +12%.CleanSpark (CLSK) +12%.MicroVision (MVIS) +11%.Losers: Condor Hospitality T...

Gainers: AcelRx Pharmaceuticals (ACRX) +17%, Cardiff Oncology (CRDF) +16%, Humanigen (HGEN) +14%, Medicenna Therapeutics (MDNA) +11%, Orgenesis (ORGS) +7%.Losers: iCAD (ICAD) -21%, Pieris Pharmaceuticals (PIRS) -19%, Legend Biot...

Humanigen  ( OTCQB:HGEND ) has priced its public offering of 8M common shares at $8.50/share, resulting in gross proceeds of ~$68M. More news on: Humanigen, Inc., HUMANIGEN INC NEW, Healthcare stocks news, , Read more ...

Humanigen, Inc. (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab, announced today that it has priced its underwritten public offer...

Note: This article was published on our blog on September 13, 2020 More than meets the AudioEye - PM Summary AudioEye ( AEYE ) is a software-as-a-service ( SAAS ) company that provides website accessibility compliance – in plain English, it claims to use machine learning/AI to...

Humanigen ( OTCQB:HGEN )   -1%   announced that it has commenced an underwritten public offering of 8M shares of common stock. More news on: Humanigen, Inc., , Healthcare stocks news Read more ...